Weixinkang Medicine to terminate sub-project in IPO-funded project

Summary: On 8 May, Weixinkang Medicine announced its intention to terminate "Multivitamins for Injection (12)", a sub-project within the IPO-funded "new products development project" (implemented by Baiyi Pharma).On 8 May, Tibet Weixinkang Medicine C...

Vitamins China E-News 202405

www.cnchemicals.com